Enhanced phosphorylation of AKT was also demonstrated by the treatment of breast cancer cell lines with AZD5363 as a consequence of the protein being held in a hyperphosphorylated but catalytically inactive form following compound binding [12]. Here, AKT1 is linked to breast carcinoma.